Galenic composition containing opioid antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/485 (2006.01) A61K 9/16 (2006.01) A61K 9/48 (2006.01) A61K 9/50 (2006.01)

Patent

CA 2273353

A pharmaceutical composition for oral administration contains naloxone-, N- methylnaloxone- and/or N-methylnaltrexone-containing particles which release the active substance depending on the ambient pH. This ensures the liberation of the active substance over the whole gastrointestinal tract. The side effects caused by the use of analgesic opioids, such as constipation, are thus eliminated without reducing the analgesic effect.

Cette composition pharmaceutique à administration orale contient des particules de naloxone, de N-méthylnaloxone et/ou de N-méthylnaltréxone qui libèrent le principe actif en fonction du pH ambiant, ce qui assure la libération du principe actif dans tout le conduit gastro-intestinal. Les effets secondaires causés par l'administration d'analgésiques aux opioïdes, tels que la constipation, sont ainsi éliminés sans réduire l'effet analgésique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Galenic composition containing opioid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenic composition containing opioid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic composition containing opioid antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1786493

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.